ARTICLE | Clinical News
Totect dexrazoxane regulatory update
June 5, 2006 7:00 AM UTC
CHMP issued a positive opinion for Savene dexrazoxane, a topoisomerase II inhibitor, to treat accidental extravasation of anthracycline chemotherapeutics. An NDA for Savene has Priority Review for t...